Stay updated with OneDNA media highlights, press releases, and news coverage featuring advancements in genomics, innovation, and preventive healthcare solutions
OneDNA is committed to making clinically relevant and affordable genomic testing accessible to individuals, clinicians, and healthcare partners across India. Our portfolio spans preventive genomics, pharmacogenomics, clinical genetics, microbiome analysis, maternal screening, and newborn screening, enabling informed health decisions across the life continuum.
Facing issue in account approval? email us at info@ipt.pw
FREE SEO TOOLS to Explore
Read real patient stories from OneDNA showcasing how genetic testing supports early detection, preventive care, and better health outcomes for all patients.
OneDNA is committed to making clinically relevant and affordable genomic testing accessible to individuals, clinicians, and healthcare partners across India. Our portfolio spans preventive genomics, pharmacogenomics, clinical genetics, microbiome analysis, maternal screening, and newborn screening, enabling informed health decisions across the life continuum.
OneDNA is committed to making clinically relevant and affordable genomic testing accessible to individuals, clinicians, and healthcare partners across India. Our portfolio spans preventive genomics, pharmacogenomics, clinical genetics, microbiome analysis, maternal screening, and newborn screening, enabling informed health decisions across the life continuum.
Have questions about DNA or genetic testing? OneDNA's expert consultation team in Hyderabad is always ready to guide you. Contact us today for quick support!
OneDNA is committed to making clinically relevant and affordable genomic testing accessible to individuals, clinicians, and healthcare partners across India. Our portfolio spans preventive genomics, pharmacogenomics, clinical genetics, microbiome analysis, maternal screening, and newborn screening, enabling informed health decisions across the life continuum.
OneDNA is committed to making clinically relevant and affordable genomic testing accessible to individuals, clinicians, and healthcare partners across India. Our portfolio spans preventive genomics, pharmacogenomics, clinical genetics, microbiome analysis, maternal screening, and newborn screening, enabling informed health decisions across the life continuum.
Newborn screening by OneDNA helps detect genetic and metabolic disorders early, enabling timely treatment and better long-term health outcomes for your baby.
Newborn screening is a simple, safe heel-prick blood test performed within the first 24–72 hours after birth to detect serious but treatable congenital and metabolic disorders, often before any symptoms appear. The test uses a Dried Blood Spot (DBS) card collected via heel prick and is analysed using advanced technologies including ELISA, TMS, GC-MS, and LC-MSMS at ISO-certified laboratories.
Newborn screening is a simple, safe heel-prick blood test performed within the first 24–72 hours after birth to detect serious but treatable congenital and metabolic disorders, often before any symptoms appear. The test uses a Dried Blood Spot (DBS) card collected via heel prick and is analysed using advanced technologies including ELISA, TMS, GC-MS, and LC-MSMS at ISO-certified laboratories.
Maternal Cell Contamination (MCC) testing detects maternal DNA in fetal samples to ensure accurate prenatal genetic results and prevent diagnostic errors.
Maternal Cell Contamination (MCC) occurs when maternal cells mix with fetal or placental tissue during prenatal procedures like CVS or amniocentesis. Since maternal and fetal DNA are ~50% similar, even small amounts of maternal cells can mask fetal mutations or cause false results potentially leading to misdiagnosis of aneuploidy if undetected.
Maternal Cell Contamination (MCC) occurs when maternal cells mix with fetal or placental tissue during prenatal procedures like CVS or amniocentesis. Since maternal and fetal DNA are ~50% similar, even small amounts of maternal cells can mask fetal mutations or cause false results potentially leading to misdiagnosis of aneuploidy if undetected.
View OneDNA awards and recognitions highlighting excellence in genetic testing, innovation, and contributions to advanced genomics and preventive healthcare.
OneDNA is committed to making clinically relevant and affordable genomic testing accessible to individuals, clinicians, and healthcare partners across India. Our portfolio spans preventive genomics, pharmacogenomics, clinical genetics, microbiome analysis, maternal screening, and newborn screening, enabling informed health decisions across the life continuum.
OneDNA is committed to making clinically relevant and affordable genomic testing accessible to individuals, clinicians, and healthcare partners across India. Our portfolio spans preventive genomics, pharmacogenomics, clinical genetics, microbiome analysis, maternal screening, and newborn screening, enabling informed health decisions across the life continuum.
Worried about testicular cancer risk? Discover how genetic testing enables early detection, prevention, and personalized care with expert insights from OneDNA.
Sudden cardiac arrest (SCA) is one of the most devastating cardiovascular emergencies. SCA happens when the electrical system of the heart malfunctions, resulting in deadly arrhythmias, as opposed to a heart attack, which is brought on by limited blood supply to the heart muscle. Since survival rates are still poor, prevention is a top public health priority.
1 to 1.6 million sudden cardiac deaths occur in India every year. A study
Sudden cardiac arrest (SCA) is one of the most devastating cardiovascular emergencies. SCA happens when the electrical system of the heart malfunctions, resulting in deadly arrhythmias, as opposed to a heart attack, which is brought on by limited blood supply to the heart muscle. Since survival rates are still poor, prevention is a top public health priority.
1 to 1.6 million sudden cardiac deaths occur in India every year. A study
Invasive prenatal testing in Hyderabad by OneDNA including karyotype analysis for detecting chromosomal abnormalities with expert care and precise results.
An invasive prenatal test is a diagnostic procedure performed during pregnancy to obtain fetal cells directly from the womb, providing definitive confirmation of genetic and chromosomal conditions rather than just risk estimation. Procedures such as Amniocentesis performed at 15–20 weeks and Chorionic villus sampling (CVS) performed at 13 weeks gestation.
An invasive prenatal test is a diagnostic procedure performed during pregnancy to obtain fetal cells directly from the womb, providing definitive confirmation of genetic and chromosomal conditions rather than just risk estimation. Procedures such as Amniocentesis performed at 15–20 weeks and Chorionic villus sampling (CVS) performed at 13 weeks gestation.
Non-invasive prenatal testing in Hyderabad by OneDNA for early detection of fetal genetic conditions. Safe, accurate screening with highly reliable results.
Non-Invasive Prenatal Testing (NIPT, also called NIPS) is a genetic test performed during pregnancy to analyse tiny fragments of fetal DNA (called cell-free DNA) that circulate in the mother’s bloodstream. It helps detect numerical abnormalities responsible for conditions like Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18) and Patau syndrome (Trisomy 13).
Non-Invasive Prenatal Testing (NIPT, also called NIPS) is a genetic test performed during pregnancy to analyse tiny fragments of fetal DNA (called cell-free DNA) that circulate in the mother’s bloodstream. It helps detect numerical abnormalities responsible for conditions like Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18) and Patau syndrome (Trisomy 13).
Maternal serum screening by OneDNA helps assess risk of chromosomal abnormalities and neural tube defects during pregnancy with accurate and reliable results.
Maternal Serum Screening (MSS), often called the "Dual Screen" or "First Trimester Combined Screening," is a non-invasive prenatal test performed on a sample of the mother's blood. It analyses specific proteins and hormones produced by the placenta and fetus that can indicate an increased chance for certain chromosomal conditions and neural tube defects. It is important to understand: MSS is a screening test, not a diagnostic test. It
Maternal Serum Screening (MSS), often called the "Dual Screen" or "First Trimester Combined Screening," is a non-invasive prenatal test performed on a sample of the mother's blood. It analyses specific proteins and hormones produced by the placenta and fetus that can indicate an increased chance for certain chromosomal conditions and neural tube defects. It is important to understand: MSS is a screening test, not a diagnostic test. It
Carrier screening test by OneDNA helps identify inherited genetic risks before pregnancy, enabling informed family planning and reducing chances of passing conditions.
Carrier screening is a genetic test that identifies individuals who carry pathogenic variants associated with autosomal recessive disorders. Carriers are typically asymptomatic, as they possess one normal and one mutated allele. However, if both partners carry variants in the same gene, there is a 25% risk in each pregnancy of having an affected child, making carrier screening essential for accurate reproductive risk assessmen
Carrier screening is a genetic test that identifies individuals who carry pathogenic variants associated with autosomal recessive disorders. Carriers are typically asymptomatic, as they possess one normal and one mutated allele. However, if both partners carry variants in the same gene, there is a 25% risk in each pregnancy of having an affected child, making carrier screening essential for accurate reproductive risk assessmen
Find the best DNA test kits from OneDNA for preventive health and personalized care. Start your genetic journey with trusted, expert-backed solutions today now.
OneDNA is committed to making clinically relevant and affordable genomic testing accessible to individuals, clinicians, and healthcare partners across India. Our portfolio spans preventive genomics, pharmacogenomics, clinical genetics, microbiome analysis, maternal screening, and newborn screening, enabling informed health decisions across the life continuum.
Lords Mark Industries, a diversified conglomerate with over 27 years of le
OneDNA is committed to making clinically relevant and affordable genomic testing accessible to individuals, clinicians, and healthcare partners across India. Our portfolio spans preventive genomics, pharmacogenomics, clinical genetics, microbiome analysis, maternal screening, and newborn screening, enabling informed health decisions across the life continuum.
Lords Mark Industries, a diversified conglomerate with over 27 years of le
OneDNA delivers advanced genetic testing and genomics solutions, supporting early diagnosis, preventive care, and personalized health insights for outcomes.
OneDNA is committed to making clinically relevant and affordable genomic testing accessible to individuals, clinicians, and healthcare partners across India. Our portfolio spans preventive genomics, pharmacogenomics, clinical genetics, microbiome analysis, maternal screening, and newborn screening, enabling informed health decisions across the life continuum.
Lords Mark Industries, a diversified conglomerate with over 27 years of legacy
OneDNA is committed to making clinically relevant and affordable genomic testing accessible to individuals, clinicians, and healthcare partners across India. Our portfolio spans preventive genomics, pharmacogenomics, clinical genetics, microbiome analysis, maternal screening, and newborn screening, enabling informed health decisions across the life continuum.
Lords Mark Industries, a diversified conglomerate with over 27 years of legacy
OneDNA offers advanced DNA testing & personalized genetic counseling in Hyderabad. Discover your hidden health risks early and act now. Book your test today!
OneDNA is committed to making clinically relevant and affordable genomic testing accessible to individuals, clinicians, and healthcare partners across India. Our portfolio spans preventive genomics, pharmacogenomics, clinical genetics, microbiome analysis, maternal screening, and newborn screening, enabling informed health decisions across the life continuum.
Lords Mark Industries, a diversified conglomerate with over 27 years of legac
OneDNA is committed to making clinically relevant and affordable genomic testing accessible to individuals, clinicians, and healthcare partners across India. Our portfolio spans preventive genomics, pharmacogenomics, clinical genetics, microbiome analysis, maternal screening, and newborn screening, enabling informed health decisions across the life continuum.
Lords Mark Industries, a diversified conglomerate with over 27 years of legac